Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$122M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$89.5M |
| 3 |
Microsoft
MSFT
|
+$71.3M |
| 4 |
Visa
V
|
+$67M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$61.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$59M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$48.4M |
| 5 |
Amgen
AMGN
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.69% |
| 2 | Industrials | 5.51% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Healthcare | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Okta
OKTA
$22.7B
| $727K | ﹤0.01% |
7,769
-52,126
| -87% | -$4.93M |
|
1627
CALL
Pinterest
PINS
$13.3B
| $727K | ﹤0.01% |
16,500
-600
| -4% | -$23.7K |
|
1628
Oppenheimer Holdings
OPY
$1.24B
| $726K | ﹤0.01% |
15,159
-8,682
| -36% | -$371K |
|
1629
Anika Therapeutics
ANIK
$291M
| $725K | ﹤0.01% |
28,627
-7,420
| -21% | -$192K |
|
1630
CALL
TKO Group
TKO
$14.2B
| $724K | ﹤0.01% |
+6,700
| New | +$680K |
|
1631
CALL
Caesars Entertainment
CZR
$6.05B
| $723K | ﹤0.01% |
+18,200
| New | +$684K |
|
|
SLNO
1632
DELISTED
Soleno Therapeutics
SLNO
| $722K | ﹤0.01% |
17,702
+1,508
| +9% | +$63.9K |
|
1633
PUT
Nutanix
NTNX
$17.9B
| $722K | ﹤0.01% |
+12,700
| New | +$780K |
|
1634
Mizuho Financial
MFG
$126B
| $721K | ﹤0.01% |
170,475
+150,193
| +741% | +$595K |
|
1635
Vitesse Energy
VTS
$707M
| $721K | ﹤0.01% |
30,402
+8,728
| +40% | +$207K |
|
1636
CALL
Abbott
ABT
$200B
| $717K | ﹤0.01% |
6,900
-50,100
| -88% | -$5.31M |
|
1637
CALL
Cracker Barrel
CBRL
$1.31B
| $717K | ﹤0.01% |
+17,000
| New | +$912K |
|
1638
PUT
WIX.com
WIX
$3.53B
| $716K | ﹤0.01% |
+4,500
| New | +$646K |
|
|
DAWN
1639
DELISTED
Day One Biopharmaceuticals
DAWN
| $715K | ﹤0.01% |
51,891
+8,301
| +19% | +$121K |
|
1640
CALL
Kenvue
KVUE
$37B
| $713K | ﹤0.01% |
39,200
+11,300
| +41% | +$219K |
|
1641
MannKind Corp
MNKD
$1.36B
| $709K | ﹤0.01% |
135,893
+982
| +0.7% | +$4.46K |
|
1642
PUT
DaVita
DVA
$11.3B
| $707K | ﹤0.01% |
+5,100
| New | +$703K |
|
1643
CVRx
CVRX
$86.9M
| $706K | ﹤0.01% |
58,916
+114
| +0.2% | +$1.31K |
|
1644
CALL
Progressive
PGR
$129B
| $706K | ﹤0.01% |
3,400
+1,600
| +89% | +$335K |
|
1645
CALL
Expedia Group
EXPE
$40.4B
| $706K | ﹤0.01% |
5,600
+1,500
| +37% | +$185K |
|
1646
PUT
Martin Marietta Materials
MLM
$37.6B
| $704K | ﹤0.01% |
+1,300
| New | +$756K |
|
1647
Mirion Technologies
MIR
$3.64B
| $703K | ﹤0.01% |
+65,499
| New | +$696K |
|
1648
CALL
General Mills
GIS
$21.6B
| $702K | ﹤0.01% |
11,100
-33,900
| -75% | -$2.33M |
|
1649
CleanSpark
CLSK
$3.16B
| $702K | ﹤0.01% |
+44,010
| New | +$740K |
|
1650
AMC Entertainment Holdings
AMC
$2.43B
| $700K | ﹤0.01% |
+140,662
| New | +$565K |
|
Similar funds
Paul Tudor Jones's Q2 2024 Portfolio in Review
As of Q2 2024, Paul Tudor Jones held 2,929 positions worth $19.5B, up 24% from $15.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Paul Tudor Jones deployed $4.18B of net new capital in Q2 2024, opening 786 new positions and adding to 755 existing holdings. Its largest new stake was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $59M trimmed.
- Paul Tudor Jones's largest Q2 2024 buy was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
- Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $122M increase.
- Paul Tudor Jones's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $59M.
- Paul Tudor Jones fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $277M.
- Paul Tudor Jones's ten largest holdings make up 34% of its $19.5B portfolio in Q2 2024.
- Paul Tudor Jones opened 786 new positions and closed 671 in Q2 2024.
- Paul Tudor Jones's portfolio value rose 24% quarter-over-quarter to $19.5B.
Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.